The global centrifuge market size was valued at USD 508.88 million in 2025 and is projected to grow from USD 531.78 million in 2026 to USD 756.24 million by 2034, registering a CAGR of 4.5% during the forecast period from 2026 to 2034. North America dominated the centrifuge market with a market share of 37.2% in 2025.
A centrifuge is a laboratory instrument used to separate components of a mixture based on their densities by spinning the mixture at high velocities. This process generates centrifugal force, which induces denser substances to migrate to the bottom of the container while less dense substances remain closer to the top. Centrifuges are frequently employed in various scientific and medical applications, such as the separation of blood components, the isolation of proteins, and the purification of cells.
Download a Free Sample To learn more about this report,
Growing Adoption of Smart and Workflow-Oriented Centrifuges
The centrifuge market is increasingly moving toward systems with smarter controls, programmable workflows, automatic rotor recognition, ergonomic interfaces, and simplified sample handling. Laboratories are looking for centrifuges that can reduce setup time, improve repeatability, and support higher throughput without increasing operator workload. These capabilities are particularly valuable in pharmaceutical, biotechnology, molecular biology, and academic laboratories where large numbers of samples must be processed consistently.
The shift toward more intelligent and standardized laboratory equipment is becoming one of the important centrifuge market trends as research facilities prioritize productivity and reproducibility.
Increasing Demand for Higher-Capacity Bioprocessing and Cell-Therapy Workflows
Centrifugation remains important in cell harvesting, washing, sample preparation, clarification, and other bioprocessing activities. As biologics and cell therapies move toward commercial-scale production, manufacturers require systems and workflows capable of handling more material while maintaining contamination control, process consistency, and product quality. This is encouraging investment in more automated and scalable separation technologies.
The expansion of high-throughput advanced-therapy manufacturing is increasing the importance of efficient separation and cell-processing technologies across the centrifuge industry.
Growing Demand for High-Throughput Life Science Research
The centrifuge market growth is being supported by expanding pharmaceutical, biotechnology, diagnostics, genomics, proteomics, and academic research activities. Centrifuges are routinely used for cell separation, nucleic-acid preparation, protein purification, sample clarification, and other laboratory processes. Increasing sample volumes and more complex experiments are encouraging laboratories to invest in equipment offering higher throughput, improved temperature control, flexible rotor configurations, and faster processing.
Greater research activity and larger analytical workloads continue to strengthen centrifuge market demand across life-science laboratories.
High Equipment, Rotor, and Maintenance Costs
Advanced centrifuges can require substantial investment, particularly refrigerated, high-speed, and ultracentrifuge systems. Laboratories must consider not only the initial instrument cost but also rotors, adapters, calibration, preventive maintenance, certification, and repair expenses. High rotational speeds also place considerable stress on mechanical components, making inspection and rotor management essential for safe operation.
These expenses can restrict centrifuge market size among smaller laboratories, universities, diagnostic centers, and research facilities operating with limited capital budgets.
Expansion of Cell and Gene Therapy Manufacturing
The rapid commercialization of cell and gene therapies creates a significant opportunity for centrifuge manufacturers because these workflows require repeated cell washing, harvesting, concentration, and sample-preparation steps. Producers increasingly need closed, automated, GMP-compatible equipment capable of supporting sensitive biological materials while reducing manual intervention and contamination risks.
Growth in commercial cell and gene therapy manufacturing provides manufacturers with opportunities to strengthen centrifuge market share through specialized equipment designed for regulated bioprocessing environments.
Improving Energy Efficiency While Maintaining Cooling and Performance
Refrigerated centrifuges consume substantial energy because they must maintain stable temperatures while operating at high rotational speeds. Manufacturers therefore face the challenge of reducing electricity consumption without compromising acceleration, deceleration, cooling performance, temperature stability, or sample protection. This becomes increasingly important as laboratories introduce sustainability targets and evaluate the energy footprint of scientific equipment.
Balancing energy efficiency with speed, cooling reliability, sample integrity, and operational performance will remain an important challenge as the centrifuge market expands across increasingly demanding laboratory and bioprocessing applications.
Refrigerated Centrifuge Segment Dominated the Market with 21.8% Share
The refrigerated centrifuge segment dominated the global centrifuge market with a 21.8% share, valued at USD 110.94 million in 2025. Refrigerated centrifuges are widely used for temperature-sensitive biological samples, including blood, proteins, enzymes, DNA, RNA, and cell cultures. Their ability to maintain controlled temperatures during high-speed separation makes them particularly important across clinical diagnostics, pharmaceutical research, biotechnology, and life sciences laboratories.
The microcentrifuge segment is witnessing steady growth due to its widespread use in molecular biology, genomics, clinical testing, and routine laboratory workflows. Compact designs and the ability to efficiently process small sample volumes support adoption across research and diagnostic laboratories.
The analytical ultracentrifuges segment is gaining demand as researchers increasingly require advanced systems for studying proteins, nanoparticles, macromolecules, and other biological materials. Their ability to provide detailed information on molecular size, interactions, and sample characteristics supports specialized research applications.
Request Customizationto receive a tailored report.
Clinical Diagnostic Segment Dominated the Market with 43.7% Share
The clinical diagnostic segment dominated the global centrifuge market with a 43.7% share, valued at USD 222.38 million in 2025. Centrifuges are routinely used to separate blood, urine, plasma, serum, and other biological samples before diagnostic analysis. Growing volumes of laboratory testing, expanding healthcare infrastructure, and increasing demand for accurate and timely diagnostic results continue to support the segment's leading position.
The biotherapeutic manufacturing segment is projected to register the fastest growth. Centrifuges play an important role in cell harvesting, clarification, purification, and other separation processes involved in producing vaccines, monoclonal antibodies, recombinant proteins, and cell-based therapies.
The research and development segment continues to experience strong demand as universities, research institutions, biotechnology companies, and pharmaceutical laboratories use centrifuges extensively for molecular biology, cell biology, genomics, and drug discovery workflows.
Clinical and Pathology Laboratories Segment Dominated the Market with 39.6% Share
The clinical and pathology laboratories segment dominated the global centrifuge market with a 39.6% share, valued at USD 201.52 million in 2025. These laboratories depend heavily on centrifugation for routine blood processing, serum and plasma separation, urine analysis, and other diagnostic procedures. Rising diagnostic testing volumes and increasing adoption of automated laboratory workflows continue to strengthen demand for reliable centrifuge systems.
The pharmaceutical and biotechnology companies segment is projected to register the fastest growth. Increasing biopharmaceutical research, drug development, vaccine production, cell culture activities, and biologics manufacturing are creating greater demand for high-performance centrifugation technologies.
The academic and research institutes segment is witnessing steady growth due to increasing life sciences research and expanding studies in molecular biology, genetics, microbiology, and cellular sciences. Centrifuges remain essential laboratory equipment for sample preparation and separation across these research activities.
Speak to an Analystto discuss market opportunities.
North America centrifuge market accounted for 37.2% of the global market, reaching USD 189.30 million in 2025, making it the dominant regional market. The region is projected to grow at a CAGR of 6.3% during the forecast period. Well-developed healthcare infrastructure, strong biotechnology and pharmaceutical industries, and continued investment in clinical and life sciences research are supporting demand for centrifuges. Laboratories are also moving toward automated, energy-efficient, and safer centrifuge systems to improve sample processing and reduce manual handling.
The US market was valued at USD 161.00 million in 2025, making it the largest contributor in North America. Extensive pharmaceutical and biotechnology research, a large network of clinical laboratories, and continued investment in drug development and diagnostic testing are supporting centrifuge demand. Growing adoption of automated laboratory equipment is also helping improve workflow efficiency and sample handling.
Canada's market reached USD 28.30 million in 2025. Investments in healthcare research, expanding biotechnology activities, university laboratories, and growing demand for advanced diagnostic equipment continue to support market development. Increasing laboratory automation is further encouraging the replacement of conventional equipment with modern centrifuge systems.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific centrifuge market accounted for 24.8% of the global market, reaching USD 126.20 million in 2025, and is projected to register the fastest CAGR of 8.2% during the forecast period. Expanding healthcare infrastructure, increasing pharmaceutical manufacturing, growth in biotechnology research, and rising investments in diagnostic laboratories are accelerating regional demand. Government support for healthcare and scientific research is also improving access to advanced laboratory equipment across developing economies.
China's market was valued at USD 58.90 million in 2025, making it a major contributor in Asia Pacific. Expansion of pharmaceutical manufacturing, biotechnology research, hospital laboratories, and diagnostic testing facilities continues to increase demand for centrifuges. Domestic investment in life sciences and laboratory automation is also supporting wider adoption of advanced systems.
Japan's market reached USD 23.40 million in 2025. Its established pharmaceutical sector, advanced healthcare infrastructure, strong life sciences research base, and demand for precise laboratory equipment continue to support the market. Increasing use of automated and high-performance centrifuges in research and clinical applications further strengthens demand.
Europe centrifuge market accounted for 27.1% of the global market, reaching USD 137.91 million in 2025, and is expected to grow at a CAGR of 6.5% during the forecast period. Strong pharmaceutical and biotechnology research, established healthcare systems, and continued investment in academic and clinical laboratories are supporting market expansion. Demand is increasingly shifting toward centrifuges offering improved automation, energy efficiency, safety, and sample-processing accuracy.
Germany's market accounted for USD 40.00 million in 2025. A strong pharmaceutical and biotechnology industry, extensive scientific research infrastructure, and well-developed diagnostic laboratories continue to support centrifuge adoption. Demand for reliable and automated laboratory equipment is also encouraging technological upgrades.
The UK market was valued at USD 31.30 million in 2025. Strong biomedical research, pharmaceutical development, university research programs, and clinical diagnostics are supporting demand for laboratory centrifuges. Continued investment in life sciences and laboratory automation is creating opportunities for advanced centrifuge technologies.
Latin America centrifuge market accounted for 6.1% of the global market, totaling USD 31.04 million in 2025, and is projected to grow at a CAGR of 7.1% during the forecast period. Expansion of diagnostic laboratories, improvements in healthcare infrastructure, growing pharmaceutical activities, and increasing investment in medical research are supporting regional demand for laboratory equipment.
Brazil's market was valued at USD 18.60 million in 2025, making it a major contributor in Latin America. Expansion of hospitals and diagnostic laboratories, pharmaceutical production, academic research, and increasing healthcare investment continue to support demand for centrifuge systems.
Middle East & Africa centrifuge market accounted for 4.8% of the global market, reaching USD 24.43 million in 2025, and is anticipated to grow at a CAGR of 6.6% during the forecast period. Healthcare modernization, expansion of diagnostic services, increasing medical research activities, and investment in hospital and laboratory infrastructure are gradually strengthening centrifuge demand across the region.
The UAE market was valued at USD 6.80 million in 2025. Continued investment in healthcare infrastructure, advanced diagnostic facilities, medical research, and laboratory modernization is supporting centrifuge adoption. The country's growing focus on biotechnology and specialized healthcare services is also creating opportunities for advanced laboratory equipment.
The global centrifuge industry is moderately fragmented, with established laboratory equipment manufacturers, clinical diagnostics companies, and specialized centrifugation technology providers competing across research, healthcare, biotechnology, pharmaceutical, and bioprocessing applications. Key players include Thermo Fisher Scientific, Eppendorf SE, Sartorius AG, Andreas Hettich GmbH & Co. KG, Drucker Diagnostics, Sigma Laborzentrifugen, KUBOTA Corporation, and other regional manufacturers.
Industry participants are increasingly focusing on workflow automation, high-capacity systems, advanced rotor designs, energy-efficient refrigeration, touchscreen controls, and flexible sample processing. Manufacturers are also developing centrifuges that simplify laboratory workflows, accommodate multiple tube formats, improve operator safety, and support higher sample throughput across clinical and life-science laboratories.
Drucker Diagnostics: An Emerging Market Player
Drucker Diagnostics specializes in clinical centrifugation equipment for hospitals, laboratories, clinics, and physician offices. The company focuses on practical, high-throughput centrifuge systems designed to simplify sample processing and improve turnaround times in demanding clinical environments.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Bovine Serum Market Size, Share, Growth, Analysis, Report, 2034
Asia Pacific TB Diagnostics Market Size, Share & Growth Graph by 2034
South Korea Epigenetics Market Size, Supply & Growth Report 2034
Europe Tangential Flow Filtration Market Size, Share & Trends | Industry Report, 2034
Asia Pacific Genetic Testing Market Size, 2034
North America TB Diagnostics Market Size & Trends Analysis, 2034
We are featured on:
sales@straitsresearch.com